# VISIODOL: Validation of the VISIODOL® Scale

> **NCT03968991** · NA · TERMINATED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 37 (actual)

## Conditions studied

- Visual Deficiency
- Congenital Blindness
- Acquired Blindness

## Interventions

- **DIAGNOSTIC_TEST:** VISIODOL® (Diagnostic tool)

## Key facts

- **NCT ID:** NCT03968991
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-18
- **Primary completion:** 2020-12-28
- **Final completion:** 2020-12-28
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** low recruits
- **Last updated:** 2023-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03968991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03968991, "VISIODOL: Validation of the VISIODOL® Scale". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03968991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*